2011-08-12T13:50:16-05:00 2011-03-31 MOSS ADAMS LLP 9665 GRANITE RIDGE DRIVE SUITE 600 SAN DIEGO CA 92123 990 2010-04-01 954002032 ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH ALFR 6617026700 25134 RYE CANYON LOOP NO 200 SANTA CLARITA CA 91355 DAVID HANKIN 6617026700 2011-08-12 1 PATRICIA J MAYER 8586271400 2010 2016-02-24 21:20:13Z DAVID HANKIN 25134 RYE CANYON LOOP NO 200 SANTA CLARITA CA 91355 44721242 0 X WWW.AEMF.ORG X 1985 CA CONDUCT MEDICAL AND SCIENTIFIC RESEARCH 5 4 137 12 0 0 1212647 990071 0 0 10683025 8294980 12156878 3081838 24052550 12366889 0 36000 0 0 11285757 13055840 0 0 396110 8743356 8903530 20029113 21995370 4023437 -9628481 152696549 149147272 14888708 15477095 137807841 133670177 X THE ALFRED MANN FOUNDATION IS A MEDICAL RESEARCH ORGANIZATION DEDICATED TO BRINGING ADVANCED MEDICAL TECHNOLOGIES TO THE PUBLIC TO PROVIDE SIGNIFICANT IMPROVEMENTS TO THE HEALTH, SECURITY AND QUALITY OF LIFE FOR PEOPLE SUFFERING FROM DEBILITATING MEDICAL CONDITIONS. 0 0 7146202 36000 THE FUNCTION ELECTRICAL STIMULATION BATTERY POWERED MICROSTIMULATOR (FEBPM) PROGRAM (FORMERLY THE BATTERY POWERED MICROSTIMULATOR (BPM) PROGRAM) IS THE DEVELOPMENT OF THE NEXT-GENERATION MICROSTIMULATOR SYSTEM. IT IS DESIGNED FOR A WIDE RANGE OF MEDICAL APPLICATIONS INCLUDING LOCALIZED INDIVIDUAL MUSCLE CONTROL AND ORCHESTRATED MUSCLE GROUP CONTROL. THE PRESENT MICROSTIMULATOR (RFM - SEE BELOW) IS POWERED AND CONTROLLED THROUGH AN EXTERNAL RF FIELD AND ONLY A FEW MICROSTIMULATORS CAN BE CONTROLLED AT ONCE USING A CONTROL ALGORITHM INSTALLED ON A PC AND UTILIZING LIMITED ACTIVITY SEQUENCES. BY CONTRAST, THE FEBPM IMPLANT HAS ITS OWN POWER SUPPLY WHICH CAN BE RECHARGED AS NEEDED AND THEN CAN OPERATE FOR PERIODS OF TIME. NUMEROUS FEBPM'S CAN BE COMMUNICATED WITH AND CONTROLLED USING ONE EXTERNAL CONTROLLER. FUTURE VERSIONS OF THE FEBPM SYSTEM MAY ALSO CONTAIN SENSORS CAPABLE OF COMMUNICATING BACK TO THE CONTROLLER TO DELIVER VARIOUS TYPES OF INFORMATION USED FOR SYSTEM OPERATION.STATUS:AN APPLICATION-SPECIFIC INTEGRATED CIRCUIT COMPRISING OF EMG SENSING CAPABILITY HAS BEEN DESIGNED, TAPED OUT AND TESTED WITH OUR COMMUNICATION SYSTEM. SYSTEM CONTROLLER AND CHARGING COMPONENTS HAVE BEEN UPGRADED AND TESTED. A NEW SET OF REQUIREMENTS ARE BEING DEVELOPED FOR THE NEXT GENERATION FEBPM SYSTEM WHERE SENSING CAPABILITY AND RICHER AND MORE USER FRIENDLY INTERFACES WILL BE IMPLEMENTED. EXTENSIVE ENGINEERING EVALUATION AND TESTS HAVE BEEN CARRIED OUT BOTH IN HOUSE AND BY EXTERNAL VENDORS TO SUPPORT THE MAJOR EFFORT TO SECURE AN ALLOCATION OF REQUIRED FREQUENCY SPECTRUM FOR THE PROGRAM. 4165201 IN DECEMBER, 2009, AMF PURCHASED THE ASSETS OF A COMPANY CALLED INFUSION SYSTEMS. THE ASSETS INCLUDED, AMONG OTHER THINGS, THE INTELLECTUAL PROPERTY AND HARD ASSETS/EQUIPMENT NECESSARY TO BUILD AN IMPLANTABLE INFUSION PUMP THAT CAN BE USED TO PUMP VARIOUS PHARMACEUTICAL PRODUCTS INTO THE HUMAN BODY SAFELY AND ACCURATELY. THE INITIAL APPLICATION IS FOR PAIN MANAGEMENT USING MORPHINE. STATUS:THE FOUNDATION SUBMITTED AND THE FDA APPROVED AN IDE APPLICATION TO START A HUMAN CLINICAL TRAIL FOR PAIN MANAGEMENT USING INFUMORPH. THREE PATIENTS WERE IMPLANTED WITH PUMPS AT TWO SEPARATE CENTERS, THE NORTH CAROLINA PAIN CENTER AND AT UC SAN DIEGO. IN PARALLEL, SYSTEM COMPONENT AND ACCESSAROY INVENTORY WAS BUILT TO SUPPORT THE 75 PATIENT HUMAN TRIAL. ON AN ONGOING BASIS, CERTAIN ENGINEERING PROJECTS WERE IN DEVELOPMENT FOCUSING ON PRODUCT IMPROVEMENT AND ADDITIONAL FUNCTIONALITY. 2985339 NEW PROJECTS: A) ICPM: INITIAL DEVELOPMENT WORK BEGAN ON A NEW TECHNOLOGY ALLOWING THE MONITORING OF INTERCRANIAL PRESSURE. THE GOAL OF THIS PROJECT IS TO COUPLE A PRESSURE SENSOR TO THE INTRA-VENTRICULAR CATHETER OF A HYDROCEPHALUS SHUNT IN ORDER TO MONITOR INTRACRANIAL CSF PRESSURE IN REAL TIME, TO MONITOR THE ADEQUACY AND EFFECTIVENESS OF INDIVIDUAL PATIENTS' SHUNT OPERATION, AND TO PROTECT THE HEALTH OF SHUNT PATIENTS. THE MAJOR AREA OF FOCUS DURING THE INTITIAL FEASIBILITY ANALYSIS IS "DRIFT" THAT RESULTS FROM VARIOUS FORCES PLACED ON THE SENSOR. OVER TIME THE BUILT IN FORCES CAUSE THE OUTPUT TO DRIFT AND RESULT IN INACCURATE READINGS.STATUS:MUTIPLE SENSORS HAVE BEEN EVALUATED BY USING A SERIES OF RIGOROUS EXPERIMENTS AND TESTS. ONE COMMERCIALLY AVAILABLE PRESSURE SENSOR THAT MEETS THE REQUIREMENTS HAS BEEN IDENTIFIED. PACKAGING METHOD TO ASSEMBLE THE SENSOR INTO AN IMPLANTABLE PACKAGE HAS BEEN DEVELOPED AND LONG TERM SOAKING TESTS WITH BARE SENSORS AND ASSEMBLED PACKAGES HAVE BEEN CONDUCTED. ASICS HAVE BEEN DESIGNED AND TESTED FOR THE POTENTIAL USE OF SUCH ICPM SYSTEM.B) AP: THE ARTIFICIAL PANCREAS DEVELOPMENT PATH CONSISTS OF SEVERAL STEPS CULMINATING IN A FULLY IMPLANTABLE, CLOSED-LOOP, AUTONOMOUS ARTIFICIAL ENDOCRINE PANCREAS. SUCH A SYSTEM WILL MAINTAIN BLOOD GLUCOSE LEVELS IN DIABETICS TO NORMAL RANGE WITHOUT RISK OF HYPOGLYCEMIA (LOW BLOOD GLUCOSE). FOUR MAJOR COMPONENTS CONSTITUTE THE AP SYSTEM: AN IMPLANTABLE PUMP DELIVERING INSULIN TO THE INTRAPERITONEAL SPACE, INSULIN WHICH IS STABLE AT BODY TEMPERATURE, AN IMPLANTABLE GLUCOSE SENSOR, AND A CONTROL ALGORITHM.STATUS: A MAJOR EFFORT AT THIS TIME IS ACQUISITION OF EXTERNAL FUNDING FOR THIS AMBITIOUS PROJECT. ONE GRANT APPLICATION HAS BEEN SUBMITTED TO NIH, ANOTHER IS IN PREPARATION, AND WE ARE MEETING WITH PRIVATE FUNDING AGENCIES. AN EXISTING IMPLANTABLE PUMP DEVELOPED BY AMF IS UNDER BENCH TESTING USING TWO CANDIDATE INSULINS. INSULINS ARE BEING TESTED FOR PHYSICAL AND CHEMICAL STABILITY. WE ARE IN THE PROCESS OF EVALUATING SEVERAL POTENTIAL GLUCOSE SENSOR PARTNERS. WE HAVE EVALUATED CONTROL ALGORITHM PARTNERS AND ARE SUBMITTING A GRANT REQUEST FOR ANIMAL STUDIES WITH ONE OF THESE INVESTIGATORS. 3765397 THE IMES PROJECT IS A CONSORTIUM PROJECT WITH THE FOLLOWING PARTNERS: NORTHWESTERN UNIVERSITY, THE ILLINOIS INSTITUTE OF TECHNOLOGY, AND SIGENICS (A CLOSELY HELD ENGINEERING COMPANY). THE INITIAL FUNDING FOR THE IMES PROGRAM IS COMING FROM THE NATIONAL INSTITUTES FOR BIOMEDICAL IMAGING AND BIOENGINEERING (NIBIB) AND THE NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (NICHD) AS WELL AS THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA). THE IMPLANTABLE MYOELECTRIC SENSOR (IMES) SYSTEM IMPLANTED IN THE RESIDUAL LIMB OF A GROSS LIMB AMPUTEE WOULD TRANSMIT NERVE SIGNALS TO THE WEARABLE PROSTHESIS TO PERMIT CONTROL OF THE PROSTHESIS IN A MORE NATURAL MANNER. INITIALLY, AMF WAS A SUBCONTRACTOR TO PROVIDE ENGINEERING AND MANUFACTURING SERVICES TO PACKAGE AN IMPLANT SUITABLE FOR FURTHER STUDY. IN THE LAST FEW YEARS, AMF HAS ASSUMED A MORE CENTRAL ROLE, PERFOMING KEY ENGINEERING TASKS AND PREPARING FOR A CLINICAL TRIAL.STATUS:AMF TOOK ON A MORE CENTRAL ROLE IN THE DEVELOPMENT OF IMES WITH THE AIM OF STARTING A FEASIBILITY CLINICAL TRIAL IN THE SUMMER OF 2012. AMF HAS BEEN WORKING ON DEVELOPING A MULTIPLE DEGREE-OF-FREEDOM PROSTHESIS WITH THE SUPPORT OF SIGENIC'S TEAM AND ANOTHER COMMERCIAL PARTNER. FUNCTIONAL PROTOTYPES OF A MULTIPLE DEGREE-OF-FREEDOM CONTROLLED WITH IMES SYSTEM HAVE BEEN DEVELOPED AND PROTOTYPES BUILT.THE RADIO FREQUENCY MICROSTIMULATOR (RFM) IS A SYSTEM OF DEVICES INTENDED TO STIMULATE NERVES TO CONTROL MUSCLE MOVEMENT IN PATIENTS WHO HAVE EXPERIENCED A DEBILITATING MUSCLE/NERVE INJURY OR DISEASE. THE SYSTEM CONSISTS OF IMPLANTED MICROSTIMULATORS, SURGICAL TOOLS USED TO IMPLANT THE MICROSTIMULATORS, EXTERNAL COMPONENTS USED TO POWER THE IMPLANTED MICROSTIMULATORS (A CONTROL UNIT AND RF COIL), AND A LAPTOP WITH CUSTOM SOFTWARE USED TO PROGRAM THE MICROSTIMULATORS. STATUS:ONE FEASIBILITY STUDY WITH THE RFM SYSTEM HAS BEEN SUCCESSFULLY CLOSED. IN CONNECTION WITH THE FEASIBILITY STUDY, ENGINEERING WORK WAS PERFORMED TO ENHANCE SYSTEM FEATURES AND FUNCTIONALITY REQUIRED TO MEET USER NEEDS. ENGINEERING AND REGULATORY ACTIVITES HAVE BEEN CARRIED OUT TO SUPPORT TWO IDE SUBMISSIONS FOR 2 RFM CLINICAL STUDIES, ONE IS ARM REHABITATION DUE TO TRAUMATIC BRAIN INJURY AND THE OTHER IS DYSPHAGIA TREATMENT FOR THROAT CANCER PATIENTS. WE ARE ANTICIPATE STARTING THE TWO CLINICAL STUDIES IN FISCAL YEAR OF 2011. 3765397 18062139 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 0 0 0 1 0 0 1 0 1 0 0 0 1 0 0 0 1 1 0 0 0 0 1 0 0 0 0 1 X 73 0 1 137 1 0 0 0 0 0 1 1 0 0 0 0 0 X 5 4 1 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X FARAH BOROOMAND 6617026731 25134 RYE CANYON LOOP SUITE 200 SANTA CLARITA CA 91355 ALFRED MANN 3.00 X 0 0 0 BRIAN MANN 2.00 X 0 0 0 KENT KRESA 2.00 X 0 0 0 ROBERT GREENBERG 2.00 X X 0 0 0 RICHARD WAUGH 2.00 X 0 0 0 MIMI DANIHEL 2.00 X 0 0 0 DAVID HANKIN 50.00 X 354500 0 45361 LAWRENCE FISCHER 40.00 X 266517 0 15834 FARAH BOROOMAND 48.00 X 186077 0 7891 MARK CHAMBERLAIN 50.00 X 254786 0 22726 DAN MERRILL 45.00 X 196389 0 18595 GUANGQIANG JIANG 43.00 X 209417 0 27994 JOHN PETROVICH 48.00 X 158639 0 16785 STEPHEN HESSELL 43.00 X 234854 0 26270 MICHAEL PERRIN 42.00 X 151221 0 13110 PETER LORD 41.00 X 180902 0 18200 EUSEBIU MATEI 40.00 X 193210 0 18717 JAMES WOLFE 40.00 X 160114 0 27695 HOWARD STOVER 40.00 X 185165 0 11223 CHARLES BYERS 41.00 X 170861 0 18452 2902652 0 288853 39 0 1 0 KAYE SCHOLER LLP 1999 AVNEUE OF THE STARS SUITE 160 LOS ANGELES CA 90067 LEGAL SERVICES 580127 PODESTA GROUP INC 1001 G STREE NW SUITE 900 E WASHINGTON DC DC 20001 PROGRAM SERVICES 302199 POKO EVENT PRODUCTIONS 10683 SANTA MONICA BLVD LOS ANGELES CA 90025 EVENT PRODUCTION SERVICES 161699 WILKINSON BARKER KNAUER LLP 2300 N STREET NW 700 WASHINGTON DC 20037 LEGAL SERVICES 141282 HENRICKS SLAVIN & HOLMES LLP 840 APOLLO STREET 200 EL SEGUNDO CA 90245 LEGAL SERVICES 131524 6 964824 25247 19500 990071 4391436 4391436 3350000 3350000 35822235 5500 31924191 3898044 5500 3903544 3903544 162000 964824 430162 -268162 -268162 12366889 3350000 0 8026818 36000 36000 2226061 1612827 613234 8986782 7797014 983317 206451 132090 114603 14453 3034 900189 745970 139212 15007 810718 703387 88707 18624 1365832 1281534 84298 96575 96575 2500446 1473695 987898 38853 1680432 1502587 145190 32655 110613 74029 34117 2467 1427624 1279342 117298 30984 200762 122730 62972 15060 73834 50504 22519 811 1216134 1111097 103427 1610 64723 53079 9249 2395 EDUCATION & MORALE 111035 89191 19892 1952 MISCELLANEOUS 30520 14550 14763 1207 OTHER FUNDRAISING EXPEN 25000 0 0 25000 21995370 18062139 3537121 396110 701170 401231 11192797 1367375 202903 614719 10000000 10078562 794964 580006 10513020 7214158 3798929 3298862 116561706 122636134 6420023 7221573 1135868 1979379 1888189 969431 152696549 149147272 2021767 2278523 12741345 12921364 125596 277208 14888708 15477095 X 137807841 133670177 137807841 133670177 152696549 149147272 X -9628481 5490817 X 0 1 1 X 0 X COUNTY USC MEDICAL CENTER LOS ANGELES CA SHEPHERD CENTER ATLANTA GA SHRINER'S CHILDREN'S HOSPITAL PHILADELPHIA PA JAMES A HALEY VA MEDICAL CENTER TAMPA FL WALTER REED ARMY MEDICAL WASHINGTON DC THE CENTER FOR CLINICAL RESEARCH WINSTONSALEM NC UCSD CENTER FOR PAIN MEDICINE SAN DIEGO CA NEUROVATIONS NAPA CA RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1481124 208867 1272257 5075963 3671558 1404405 3955933 3333733 622200 3298862 PROMISSORY NOTE PAYABLE RELATED PARTY 277208 277208 12366889 21995370 -9628481 5490817 5490817 -4137664 17857706 5490817 5490817 12366889 0 12366889 21995370 0 21995370 0 21995370 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: THE FOUNDATION, UNDER THE PROVISIONS OF ASC 740, INCOME TAXES, HAD NO UNCERTAIN TAX POSITIONS REQUIRING ACCRUAL AS OF MARCH 31, 2011. CENTRAL AMERICA AND THE CARIBBEAN INVESTMENTS 4618245 0 0 0 4618245 0 4618245 1 0 1 1 1 0 GALA 1126824 964824 162000 430162 1126824 964824 162000 430162 430162 -268162 1 AMERICAN HEART ASSOCIATION INC 816 S FIGUEROA STREET LOS ANGELES CA 90017 135613797 501(C)(3) 25000 GENERAL SUPPORT 1 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: AMOUNTS PROVIDED ARE TO PUBLIC CHARITIES, ACCOUNTING DEPARTMENT MAINTAINS BACKUP DETAILS. X X X 1 0 0 0 0 0 0 1 0 DAVID HANKIN 267500 0 75000 0 12000 0 5434 0 39927 0 399861 0 0 0 LAWRENCE FISCHER 86078 0 0 0 180439 0 1709 0 14125 0 282351 0 0 0 FARAH BOROOMAND 157540 0 28537 0 0 0 3212 0 4679 0 193968 0 0 0 MARK CHAMBERLAIN 228536 0 26250 0 0 0 4071 0 18655 0 277512 0 0 0 DAN MERRILL 170889 0 25500 0 0 0 3464 0 15131 0 214984 0 0 0 GUANGQIANG JIANG 174417 0 35000 0 0 0 3604 0 24390 0 237411 0 0 0 JOHN PETROVICH 158639 0 0 0 0 0 3199 0 13586 0 175424 0 0 0 STEPHEN HESSELL 200687 0 34167 0 0 0 3591 0 22679 0 261124 0 0 0 MICHAEL PERRIN 127221 0 24000 0 0 0 858 0 12252 0 164331 0 0 0 PETER LORD 155831 0 25071 0 0 0 2909 0 15291 0 199102 0 0 0 EUSEBIU MATEI 173945 0 19265 0 0 0 3487 0 15230 0 211927 0 0 0 JAMES WOLFE 160114 0 0 0 0 0 3328 0 24367 0 187809 0 0 0 HOWARD STOVER 168776 0 16389 0 0 0 3340 0 7883 0 196388 0 0 0 CHARLES BYERS 155655 0 15206 0 0 0 3099 0 15353 0 189313 0 0 0 PART I, LINE 7 BONUS PAYMENTS ARE BASED ON ACHIEVEMENTS, GOALS, AND ARE APPROVED BY BOARD OF DIRECTORS. SUPPLEMENTAL INFORMATION PART III A SEVERANCE PAYMENT WAS MADE TO LAWARENCE FISHER IN THE AMOUNT OF $175,000. BIONESS INC - INDIRECT 35 OWNERSHIP BY ALFRED E MANN MEMBER BRIDGE LOAN X 10000000 10000000 0 1 1 10000000 MANN BIOMEDICAL PARK LLC ENTITY MORE THAN 35% OWNED BY ALFRED E. MANN, MEMBER 708540 THE FOUNDATION IS PARTY TO TWO LEASES WITH MANN BIOMEDICAL PARK, LLC FOR THE FOLLOWING FACILITIES:25133 RYE CANYON LOOP, SANTA CLARITA FOR $2,007 PER MONTH25134 RYE CANYON LOOP, SANTA CLARITA FOR $57,038 PER MONTH 0 MANNCO LLC ENTITY MORE THAN 35% OWNED BY ALFRED E. MANN, MEMBER 497160 THE FOUNDATION IS PARTY TO ONE LEASE WITH MANNCO, LLC FOR THE FACILITY AT 28575 LIVINGSTON AVENUE, VALENCIA, FOR $41,430 PER MONTH. 0 BIONESS INC ENTITY MORE THAN 35% OWNED BY ALFRED E. MANN, MEMBER 925000 INTEREST PAID TO ORGANIZATION ON BRIDGE LOAN. 0 X 1 19500 FMV X VALUABLE ITEMS 10 0 NONE 0 0 0 NON REPORTING OF REVENUE: PART I, LINE 33: THE DONATED ITEMS WERE NOT RECORDED WHEN THEY WERE RECEIVED, BUT THE PROCEEDS FROM SELLING THEM WERE RECORDED AS REVENUE. THESE ITEMS WERE DONATED SHORTLY BEFORE THE ANNUAL FUNDRAISING EVENT. FORM 990, PART VI, SECTION A, LINE 2 BRIAN MANN AND AL MANN, FAMILY RELATIONSHIP KEN KRESA AND AL MANN, BUSINESS RELATIONSHIP ROB GREENBERG AND AL MANN, BUSINESS RELATIONSHIP FORM 990, PART VI, SECTION A, LINE 6 THE FOUNDATION HAS A SINGLE MEMBER WHO MAY APPOINT OR REMOVE MEMBERS OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7A THE FOUNDATION HAS A SINGLE MEMBER WHO MAY APPOINT OR REMOVE MEMBERS OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11 A DRAFT OF FORM 990 WAS PRESENTED BY MANAGEMENT TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS, AND A FULL COPY OF THE FORM WAS PROVIDED TO ALL VOTING MEMBERS PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST DISCLOSURES ARE UPDATED ANNUALLY AND POTENTIAL CONFLICTS ARE REVIEWED PRIOR TO PARTICIPATING IN TRANSACTIONS.IF A CONFLICT EXISTS, THE PERSON WITH A CONFLICT DOES NOT VOTE. THERE HAVE BEEN NO INCIDENCES THIS REPORTING YEAR. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE COMPENSATION OF THE CEO AND CFO. THEY ALSO REVIEW AND APPROVE THE OVERALL ANNUAL ADJUSTMENTS TO COMPENSATION OF OTHER EMPLOYEES. SPECIFIC ADJUSTMENTS FOR OTHER EMPLOYEES ARE HANDLED BY THE CEO AND HEAD OF HUMAN RESOURCES USING COMPARISONS TO SALARY SURVEYS FOR SIMILAR POSITIONS AND EXPERIENCE. DURING THE YEAR ENDED MARCH 31, 2011, THE ORGANIZATION HAD AN OUTSIDE COMPENSATION ANALYSIS COMPLETED COVERING EXECUTIVE MANAGEMENT, KEY EMPLOYEES AND HIGHLY COMPENSATED EMPLOYEES. THE BOARD OF DIRECTORS APPROVED COMPENSATION FOR THE CEO AND CFO. THIS PROCESS WAS DOCUMENTED. FORM 990, PART VI, SECTION C, LINE 19 MEMBERS OF THE PUBLIC OR INTERESTED PARTIES MAY REQUEST TO REVIEW OR RECEIVE A COPY OF THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS BY PHONE OR MAIL. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED GAINS ON INVESTMENTS: 5,490,817. FORM 990, PART V, LINE 7H: A CAR WAS DONATED TO THE ORGANIZATION FROM A DEALER, WHICH QUALIFIES AS INVENTORY, SO FORM 1098-C WAS NOT REQUIRED. ROUNDTRIP LLC 12121 WILSHIRE BLVD SUITE 700 LOS ANGELES CA 90025 RESEARCH & DEVELOPMENT OF LOCATION SYSTEMS DE N/A RELATED -690289 0 0 MANN BIOMEDICAL PARK LLC 25134 RYE CANYON LOOP VALENCIA CA 91355 PROPERTY RENTAL CA N/A INCUMED LLC 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 HOLDING COMPANY PROVIDING STRATEGIC, OPERATIONAL & COMMERCIAL SUPPORT CA N/A PERQFLO LLC 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 PUMP DEVELOPMENT COMPANY CA N/A BIONESS INC 25103 RYE CANYON LOOP VALENCIA CA 91355 DESIGN MANUFACTURE & SALE OF MEDICAL DEVICES DE N/A C 0.03980 NEUROSYSTEC CORPORATION 25134 RYE CANYON LOOP SUITE 370 VALENCIA CA 91355 PHARMACEUTICAL SOLUTIONS DEVELOPMENT CA N/A C 1 0 0 1 1 0 0 0 1 1 0 0 0 1 0 1 0 0